The most well-studied TSG targets of PcGs are the CDKN2A and CDKN2B loci encoding p14 (ARF), p15 (INK4B) and p16 (INK4A), whose products participate in major tumour suppressor networks that are disabled in human cancer. The gene discussed is CDKN2B; the disease is cancer.